Browsing Tag
Alzheimer’s
16 posts
Exploring the Alzheimer’s brain
For the first time, scientists studying Alzheimer’s disease have mapped the structure of molecules in a human brain. Published in Nature, the study used cryo-electron tomography, guided by fluorescence microscopy, to explore inside an Alzheimer’s donor brain. This provided 3D maps to observe proteins, the tiny building blocks of life, within the brain, a million
How we can slow down or prevent Alzheimer’s
Getting more than six hours of quality sleep a night may help prevent, or slow the progression of Alzheimer's disease, according to new research from Murdoch University. The study, "Suboptimal self-reported sleep efficiency and duration are associated with faster accumulation of brain amyloid beta in cognitively unimpaired older adults," is published in Alzheimer's & Dementia:
Alzheimer’s Slowed by Intensive Lifestyle Changes
Neurology > Alzheimer's Disease — Small trial led by Dean Ornish, MD, shows cognitive improvement by Judy George, Deputy Managing Editor, MedPage Today June 11, 2024 Intensive lifestyle changes improved cognitive outcomes in a phase II trial of early Alzheimer's disease. In Alzheimer's patients with mild cognitive impairment or early dementia, scores on three measures
Donanemab for Alzheimer’s Gets Thumbs Up From FDA Panel
Please enable cookies. Error 1005 Ray ID: 89290a379bd629ef • 2024-06-12 10:08:29 UTC What happened? The owner of this website (www.medscape.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 89290a379bd629ef • Your IP: 185.124.111.116 •
Alzheimer’s drug that can slow disease gets backing from FDA advisers
By MATTHEW PERRONE Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] WASHINGTON (AP) — A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease.Food and Drug Administration advisers voted unanimously
Alzheimer’s Paper Retracted; Pets and Human Cognition; Long COVID Internal Tremors
Neurology > General Neurology — News and commentary from the world of neurology and neuroscience by Judy George, Deputy Managing Editor, MedPage Today January 2, 2024 Nature announced that another Alzheimer's paper led by former Stanford president Marc Tessier-Lavigne, PhD, was retracted, identifying anomalies in the 2009 study of amyloid precursor protein (APP) and death
Lecanemab for Alzheimer's disease: An option for you?The drug lecanemab appears to slow mental decline in people with early Alzheimer's disease. Learn whether it might be right for you.By Mayo Clinic Staff Lecanemab (Leqembi) is a medicine given to slow the progression of mild Alzheimer's disease (AD). This medicine reduces clumps of proteins called amyloid-beta
Alzheimer’s Blood Tests May Improve Primary Care Diagnoses
Meeting Coverage > AAIC — Without biomarkers, primary care doctors correctly identified Alzheimer's in about 55% of cases by Judy George, Deputy Managing Editor, MedPage Today July 21, 2023 AMSTERDAM -- A blood test may improve the accuracy of Alzheimer's diagnoses in primary care, data from the BioFINDER Primary Care study suggested. Primary care physicians
Alzheimer’s Progression Delayed by Rare Genetic Variant
Neurology > Alzheimer's Disease — Finding challenges previous assumptions about disease by Judy George, Deputy Managing Editor, MedPage Today May 15, 2023 The world's second case of ascertained extreme resilience to autosomal dominant Alzheimer's disease was reported, suggesting a new way Alzheimer's progression might be delayed. A rare genetic variant of RELN, which encodes the
Their Alzheimer’s Disease Didn’t Worsen. Why?
Neurology > Alzheimer's Disease — Case reports find one healthy habit in common by Judy George, Deputy Managing Editor, MedPage Today February 3, 2023 Sustained vigorous exercise might have slowed disease progression in two patients with positive Alzheimer's biomarkers and mild cognitive impairment, two case reports suggested. At age 64, patient 1 was diagnosed with